 Influenza Vaccines
"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains.
| Descriptor ID |
D007252
|
| MeSH Number(s) |
D20.215.894.899.302
|
| Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Influenza Vaccine
- Vaccine, Influenza
- Flu Vaccines
- Influenzavirus Vaccines
- Influenza Virus Vaccines
- Influenza Virus Vaccine
- Vaccine, Influenza Virus
- Virus Vaccine, Influenza
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 0 | 2 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 3 | 0 | 3 | | 2005 | 3 | 0 | 3 | | 2006 | 5 | 2 | 7 | | 2007 | 5 | 2 | 7 | | 2008 | 3 | 0 | 3 | | 2009 | 7 | 0 | 7 | | 2010 | 9 | 1 | 10 | | 2011 | 16 | 2 | 18 | | 2012 | 12 | 3 | 15 | | 2013 | 13 | 1 | 14 | | 2014 | 8 | 3 | 11 | | 2015 | 11 | 3 | 14 | | 2016 | 5 | 4 | 9 | | 2017 | 12 | 6 | 18 | | 2018 | 9 | 3 | 12 | | 2019 | 12 | 8 | 20 | | 2020 | 18 | 5 | 23 | | 2021 | 15 | 4 | 19 | | 2022 | 13 | 1 | 14 | | 2023 | 16 | 0 | 16 | | 2024 | 16 | 2 | 18 | | 2025 | 12 | 4 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Frutos AM, Tenforde MW, Sundaresan D, Naleway AL, Irving SA, DeSilva MB, Kharbanda AB, Ong TC, Rao S, Zheng K, Gohil SK, Ball SW, Fink RV, Reed C, Garg S, Bozio CH. Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016-2017 to 2019-2020: A Retrospective Cohort Study. J Infect Dis. 2025 Oct 15; 232(4):e642-e650.
-
Lewis NM, Harker EJ, Cleary S, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Halasa NB, Lauring AS, Martin ET, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Duggal A, Felzer JR, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Ferguson SAN, Mosier J, Qadir N, Chang SY, Ginde AA, Zepeski A, Mallow C, Harris ES, Johnson NJ, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Surie D, Dawood FS, Ellington S, Self WH. Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
-
Tenforde MW, Reeves EL, Weber ZA, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Yang DH, Grannis SJ, Irving SA, Ong TC, Link-Gelles R, Salas SB, Sy LS, Lewin B, Contreras R, Zerbo O, Fireman B, Hansen J, Timbol J, Sheffield T, Bride D, Arndorfer J, VanOtterloo J, McEvoy CE, Akinsete OO, Essien IJ, Dixon BE, Rogerson C, Fadel WF, Duszynski T, Naleway AL, Barron MA, Rao S, Mayer D, Chavez C, Ball SW, Payne AB, Ray C, Dickerson M, Neelam V, Adams K, Flannery B, DeCuir J, Garg S. Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States. Clin Infect Dis. 2025 Oct 06; 81(3):667-678.
-
Irving SA, Groom HC, Belongia EA, Crane B, Daley MF, Jackson LA, Kenigsberg TA, Kuckler L, Tseng HF, Williams JTB, Zerbo O, Naleway AL. Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasons. Vaccine. 2025 Oct 03; 64:127667.
-
Yonts AB, Gaviria-Agudelo C, Ratner AJ, O'Leary ST, Paulsen GC. April 2025 ACIP Meeting Update: Influenza, COVID-19, HPV, RSV and Other Immunizations. Pediatrics. 2025 Sep 01; 156(3).
-
Silverman A, Walsh R, Santoro JD, Thomas K, Ballinger E, Fisher KS, Thomas AX, Appavu B, Kruer MC, Neilson D, Knoll J, Sharp AN, Edelman HE, Otallah S, Morgan A, Grzezulkowska A, Nguyen J, Rao LM, Hecht SM, Catalano L, Daigle H, Kronfol C, Wharton J, Adams D, Kalawi AZ, Kung M, Arellano JL, Smith L, Segal D, Feja K, Broomall E, Jayakar A, Arnold SR, Retallack H, Press CA, Gombolay G, McLaughlin MH, Kannan V, Thakkar K, Rezwan T, Hulfish E, Eid D, Meylor J, Peng D, Hurtado R, Nickerson T, Mandell I, Carbonell AU, Kerner-Rossi M, Jayaraman D, Davis M, Olivero R, Shah N, Osborne CM, Zhang B, Cortina C, Randolph AG, Rao S, LaRocca T, Van Haren KP, Wilson-Murphy M. Influenza-Associated Acute Necrotizing Encephalopathy in US Children. JAMA. 2025 08 26; 334(8):692-701.
-
Reeves EL, Dascomb K, Irving SA, Klein NP, Tartof SY, Grannis SJ, Ong TC, Ball SW, Vazquez-Benitez G, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Naleway AL, Koppolu P, Zerbo O, Jacobson KB, Fireman BH, Hansen JR, Block L, Salas SB, Bezi C, Sy LS, Reyes IAC, Dixon BE, Fadel WF, Rogerson C, Duszynski T, Mayer D, Chavez C, Barron MA, Weber ZA, Yang DH, Cheung A, Payne AB, Link-Gelles R, Adams K, Neelam V, DeSilva MB, Natarajan K, Tenforde MW, DeCuir J, Ellington S, Olson SM. Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age. Vaccine. 2025 Aug 30; 62:127483.
-
Aunins EA, Phan AT, Alameh MG, Dwivedi G, Cruz-Morales E, Christian DA, Tam Y, Bunkofske ME, Peñafiel AZ, O'Dea KM, Merolle M, Furey C, Scott P, Vonderheide RH, Hensley SE, Kedl RM, Weissman D, Hunter CA. An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses. Sci Immunol. 2025 06 06; 10(108):eads1328.
-
Gaviria-Agudelo C, Yonts AB, Kimberlin DW, O'Leary ST, Paulsen GC. October 2024 ACIP Meeting Update: Influenza, COVID-19, RSV, and Other Vaccines. Pediatrics. 2025 Apr 01; 155(4).
-
Guthmiller JJ, Yu-Ling Lan L, Li L, Fu Y, Nelson SA, Henry C, Stamper CT, Utset HA, Freyn AW, Han J, Stovicek O, Wang J, Zheng NY, Huang M, Dugan HL, Tepora ME, Zhu X, Chen YQ, Palm AE, Shaw DG, Loganathan M, Francis BF, Sun J, Chervin J, Troxell C, Meade P, Leung NHL, Valkenburg SA, Cobey S, Cowling BJ, Wilson IA, García-Sastre A, Nachbagauer R, Ward AB, Coughlan L, Krammer F, Wilson PC. Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins. Immunity. 2025 Apr 08; 58(4):980-996.e7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|